Швейцарія - німецька - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - sunitinibum - hartkapseln - sunitinibum 50 mg, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium, povidonum, magnesii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 171, gelatina, drucktinte: lacca, e 171, propylenglycolum, pro capsula. - zytostatikum - synthetika

Швейцарія - німецька - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - sunitinibum - hartkapseln - sunitinibum 12.5 mg, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 0.20 mg, povidonum k 30, magnesii stearas, kapselhülle: e 172 (rubrum), e 171, gelatina, drucktinte: lacca, e 171, propylenglycolum, pro capsula. - zytostatikum - synthetika

Швейцарія - німецька - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - sunitinibum - hartkapseln - sunitinibum 25 mg, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 0.41 mg, povidonum k 30, magnesii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 171, gelatina, drucktinte: lacca, e 171, propylenglycolum, pro capsula. - zytostatikum - synthetika

Швейцарія - німецька - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - sunitinibum - hartkapseln - sunitinibum 50 mg, cellulosum microcristallinum, mannitolum, carmellosum natricum conexum corresp. natrium max. 0.81 mg, povidonum k 30, magnesii stearas, kapselhülle: e 172 (nigrum), e 172 (rubrum), e 172 (flavum), e 171, gelatina, drucktinte: lacca, e 171, propylenglycolum, pro capsula. - zytostatikum - synthetika

Бельгія - німецька - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - sunitinib malate - hartkapsel - 12,5 mg - sunitinib malate 16.71 mg - sunitinib

Бельгія - німецька - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - sunitinib malate - hartkapsel - 25 mg - sunitinib malate 33.41 mg - sunitinib

Бельгія - німецька - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka, d.d. novo mesto - sunitinib malate - hartkapsel - 50 mg - sunitinib malate 66.83 mg - sunitinib

Європейський Союз - німецька - EMA (European Medicines Agency)

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Бельгія - німецька - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - sunitinib - hartkapsel - 12,5 mg - sunitinib 12.5 mg - sunitinib

Бельгія - німецька - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eurogenerics afgekort "e.g." - sunitinib - hartkapsel - 25 mg - sunitinib 25 mg - sunitinib